Testing effectiveness (Phase 2)Looking for participantsNCT07721025
What this trial is testing
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Who this might be right for
Friedreich AtaxiaCardiomyopathy, Secondary
Lexeo Therapeutics 26